Ten Integrated Capabilities. One Accountable Partner.

Integrated national distribution serving 5,600+ pharmacies, drugstores, hospitals, clinics, institutions, and governmental entities across all 18 Iraqi governorates — with 48-hour nationwide delivery capability.

Regional distribution centers in Basra and Erbil act as strategic hubs, while a sophisticated logistics management system provides real-time inventory tracking and minimized stockouts across both public and private healthcare sectors.

Our dedicated RA team acts as the strategic bridge between international partners and the Iraqi Ministry of Health, ensuring seamless product registration and compliance across the complete lifecycle.

• Dossier preparation — reviewing and formatting technical files (CTD/eCTD) to meet local MOH requirements
• Submission & follow-up — direct engagement with regulatory authorities to expedite review
• Lab analysis coordination — sample submission and testing with the National Quality Control Lab
• Final approval & launch — securing marketing authorization to enable commercial distribution

Global support network: our subsidiaries Dr. Health (Amman) and Sumo London (UK) provide international regulatory coordination and legalization support.

Structured market assessment and access planning that turns portfolio potential into commercial reality — grounded in local data, payer channels, and health-system relationships.

We map the Iraqi health system, benchmark competitors and prices, model demand, and sequence launches across hospital and pharmacy channels, including tender and reimbursement considerations.

Brand strategy and commercial execution at national scale — from launch campaigns and pharmacy activation to continuous performance monitoring and market-share growth.

Our commercial teams combine segmentation and targeting discipline with continuous medical-representative training, digital promotion, and promotional-material development aligned to each brand's strategy.

A field force of 150+ medical representatives and 20+ supervisors delivering scientific detailing to physicians and healthcare providers in every Iraqi governorate.

• Engagement with Key Opinion Leaders and advisory boards
• Organization and sponsorship of medical conferences and symposia
• Sponsorship of physician training programs abroad
• Continuing medical education (CME) and product training

Our scientific backbone: elevating pharmaceutical promotion from simple sales to evidence-based scientific partnership, so every launch is backed by robust clinical data and clear medical value.

• Clinical data analysis — synthesizing complex studies into clear, actionable insights
• Message development — scientifically accurate key messages that resonate with professionals
• KOL engagement — strategic relationships fostering scientific exchange and advocacy
• Medical education — scientific symposia and CME events for Iraqi doctors

GDP-aligned warehousing engineered for pharmaceutical integrity: a 7,000 m³ Baghdad main hub across four protected floors (2,280 pallet positions per floor), supported by Basra and Erbil regional hubs.

IoT-enabled sensors provide 24/7 temperature tracking for sensitive products in storage and transit, with a specialized refrigerated fleet, backup systems, security systems, FEFO inventory management, and full batch traceability.

GDP-aligned · IoT-monitored

A strategic partner for hospital tenders — ensuring reliable supply for large-scale public health requirements, with a commanding presence in both private retail and public hospital channels.

Our history includes execution of major national pharmaceutical programs with KIMADIA since 1999, giving partners institutional experience across Iraq's public procurement landscape.

Local safety coordination that protects patients and partner licenses: adverse-event intake, safety-information escalation, periodic reporting support, and product-quality complaint routing.

Note: Exact pharmacovigilance responsibilities depend on the applicable product, agreement, MAH structure, contractual responsibilities, and Iraqi regulatory requirements.

Adverse-event reporting page

Flexible partnership structures matched to each manufacturer's strategy — from classical exclusive distribution to MAH-support models and strategic joint ventures.